KPTI -23% on day; Karyopharm Therapeutics Slides on Disclosure of Cash-Retention Program for Executives (out Friday) Link To Story from MARK

KPTI -23% on day; Karyopharm Therapeutics Slides on Disclosure of Cash-Retention Program for Executives (out Friday) Link To Story from MARKETWATCH.com